LPA and atherosclerosis: In the analysis of the large UK Biobank data encompassing nearly half a million individuals, Lp(a)-associated CV risk was attenuated among those with preexisting ASCVD compared with those without (5% versus 10% higher risk conferred by a 50 nmol/L increase in Lp(a) level) [7,22].